Eric Steen Joins Flat Medical as Strategic Advisor
In a significant move for its future growth, Flat Medical, a renowned player in the precision safety technology sector for clinical procedures, has appointed Eric Steen, a veteran from the medical device industry, as their Strategic Advisor. This announcement was made on January 5, 2026, emphasizing the company's commitment to enhancing its capital strategy and market presence.
Eric Steen brings over 25 years of invaluable experience in the medical device field. His previous role at B. Braun North America saw him at the forefront of strategic initiatives and commercial execution, making him a highly regarded figure in the industry. Steen's immense expertise will be an asset to Flat Medical as they aim for expansion in both US and European markets.
In his capacity as Strategic Advisor, Steen will work closely alongside Flat Medical's executive team to refine strategies for capital acquisition and market positioning. His primary responsibilities will include strengthening the company's commercial infrastructure and guiding their approach toward the dynamic US and European capital markets. This leadership will be pivotal in forming the necessary strategic partnerships essential for rapid expansion.
Karl Tsao, Chief Strategy Officer of Flat Medical, expressed excitement over Steen's appointment, stating, "We are honored to have Eric join our advisory team. His track record of scaling medical device companies and his deep understanding of the infusion and pain management sectors align perfectly with our growth roadmap. As we execute our capital strategy, Eric's guidance becomes essential in helping us secure the right partnerships for our long-term leadership position."
Steen's career is marked by a proven ability to develop high-performance teams and implement successful market strategies. His background aligns seamlessly with Flat Medical’s portfolio, particularly in markets where safety, precision, and workflow efficiency are critical factors.
Addressing his appointment, Steen commented, "Flat Medical has built an impressive foundation with innovative technology and robust clinical evidence. I look forward to working with the leadership team to accelerate their strategic initiatives and help position the company for sustained growth in the global medical device market."
The addition of Steen is a strategic maneuver that aligns with Flat Medical's ongoing efforts to expand its influence within acute care, chronic pain management, and vascular access. As the company gears up for 2026, they have several key product launches slated, including the eagerly awaited EpiFaith CV, designed for central vascular access.
Established in Taipei, Austin, and Amersfoort, Flat Medical is dedicated to improving safety and precision in needle-based procedures. With an unwavering focus on developing next-generation solutions for anesthesia, chronic pain management, and vascular access, the company prides itself on addressing clinical complications and reducing healthcare costs through cutting-edge technology. The leadership team is confident that with Steen at the helm of strategic advising, Flat Medical will continue to set benchmarks in the medical device sector.
For more information about Flat Medical and its innovative products, visit
www.flatmedical.com.